Tymlos outperforms teriparatide in real-world fracture analysis
Radius Pharmaceuticals presented real-world evidence at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases on 12 April 2024, demonstrating…
Radius Pharmaceuticals presented real-world evidence at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases on 12 April 2024, demonstrating…
Over the past two decades, there has been a marked increase in obesity rates among US adults, with projections indicating…
At the American College of Cardiology (ACC)’s 73rd Annual Scientific Session in April 2024, the results of Eli Lilly and…
At the American College of Cardiology’s 73rd Annual Scientific Session in early April 2024, a study by Gangavelli and colleagues…
Metabolic dysfunction-associated steatohepatitis (MASH) innovator drugs witnessed an over $2.5bn increase in the total value of partnership deals from 2020…
According to the latest data from the US Centers for Disease Control and Prevention (CDC), over 64 cases of measles…
Nanoscope Therapeutics released promising top-line results for its RESTORE trial, which is studying the gene therapy MCO-010 in patients with…
Licensing agreements for innovator drugs utilising clustered regularly interspaced short palindromic repeats (CRISPR) technologies saw oncology, immunology, and central nervous system…
Drug shortages are worsening globally, leaving patients without access to essential medications, and healthcare providers struggling to find alternative treatments.…
Key opinion leaders (KOLs) interviewed by GlobalData emphasised urgent action to address inconsistent drug compliance rates in the osteoporosis disease…